I read a recent article that virtually every reviewer and staff
member at the New England Journal of Medicine has a monetary
connection to a drug company. I forget which drug it was, but out of
13 clinical trials all the negative or neutral results were
unpublished and only the 3 with positive results. No journal is
immune to corporate money.
Winsor
Long Beach, California, USA
On Jun 24, 2005, at 10:12 AM, James N. McBride wrote:
> That is why the better scientific
> journals have a rather exhaustive peer review process to try to
> screen out
> the bad stuff.
==============================================
List usage info: http://www.zuikoholic.com
List nannies: olympusadmin@xxxxxxxxxx
==============================================
|